| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/03/2003 | EP1367136A1 Method of detecting nucleotide polymorphism |
| 12/03/2003 | EP1367127A1 A method for production of plants with suppressed photorespiration and improved CO2 fixation |
| 12/03/2003 | EP1367126A1 Novel vectors for animal cells and utilization thereof |
| 12/03/2003 | EP1367125A1 Vectors for expression of biotinylated proteins in mammalian cells, and their use for identification of protein-nucleic acid interactions in vivo |
| 12/03/2003 | EP1367124A1 5' ests for secreted proteins expressed in muscle and other mesodermal tissues |
| 12/03/2003 | EP1367123A1 Neurotonin and use thereof |
| 12/03/2003 | EP1367122A1 Highly sensitive nucleic acid hybridization method and gene analysis method by using the same |
| 12/03/2003 | EP1366821A2 Spotting pin |
| 12/03/2003 | EP1366772A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 12/03/2003 | EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 12/03/2003 | EP1366368A2 Alpha synuclein aggregation assays |
| 12/03/2003 | EP1366359A1 A system and method for managing gene expression data |
| 12/03/2003 | EP1366197A2 Methods and compositions for amplification of rna sequences |
| 12/03/2003 | EP1366196A2 Methods and compositions of amplifying rna |
| 12/03/2003 | EP1366195A2 Method for the detection of nucleic acid molecules |
| 12/03/2003 | EP1366193A2 Immobilisation of ligands using saccharides |
| 12/03/2003 | EP1366192A2 Direct multiplex characterization of genomic dna |
| 12/03/2003 | EP1366189A2 Detection of pathogenic bacteria |
| 12/03/2003 | EP1366187A2 Oligonucleotides for labeling oligonucleotide probes and proteins |
| 12/03/2003 | EP1366185A2 Methods and compositions for perioperative genomic profiling |
| 12/03/2003 | EP1366184A2 Map-based genome mining method for identifying gene regulatory loci |
| 12/03/2003 | EP1366182A2 Assay for nucleic acid analysis |
| 12/03/2003 | EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease |
| 12/03/2003 | EP1366179A2 Method for the amplification and detection of dna using a transcription based amplification |
| 12/03/2003 | EP1366178A2 Method of site-specific insertion in zymomonas mobilis |
| 12/03/2003 | EP1366177A1 Cloning vectors and method for molecular cloning |
| 12/03/2003 | EP1366176A2 Synthetic genes and bacterial plasmids devoid of cpg |
| 12/03/2003 | EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 12/03/2003 | EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 12/03/2003 | EP1366173A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 12/03/2003 | EP1366172A1 Nucleic acids coding for a protein interacting with a porin channel |
| 12/03/2003 | EP1366171A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 12/03/2003 | EP1366170A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents |
| 12/03/2003 | EP1366169A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 12/03/2003 | EP1366168A1 Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 12/03/2003 | EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 12/03/2003 | EP1366166A2 Molecules for diagnostics and therapeutics |
| 12/03/2003 | EP1366165A2 G-protein coupled receptors |
| 12/03/2003 | EP1366164A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 12/03/2003 | EP1366163A2 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell |
| 12/03/2003 | EP1366162A2 Putative proteins and nucleic acids encoding same |
| 12/03/2003 | EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 12/03/2003 | EP1366160A2 Mini-dystrophin nucleic acid and peptide sequences |
| 12/03/2003 | EP1366159A2 Lymphoma associated molecules and uses therefor |
| 12/03/2003 | EP1366158A2 Trp8, trp9 and trp10, markers for cancer |
| 12/03/2003 | EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/03/2003 | EP1366156A2 Osteolevin gene polymorphisms |
| 12/03/2003 | EP1366155A1 Methods and agents for modifying human angiogenesis |
| 12/03/2003 | EP1366154A2 Modulation of meiotic recombination |
| 12/03/2003 | EP1366153A2 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| 12/03/2003 | EP1366152A2 G-protein coupled receptors |
| 12/03/2003 | EP1366151A2 Prna chimera |
| 12/03/2003 | EP1366150A2 Use of protein histidine phosphatase |
| 12/03/2003 | EP1366148A2 Differentiation of stem cells to pancreatic endocrine cells |
| 12/03/2003 | EP1366147A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27 |
| 12/03/2003 | EP1366146A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof |
| 12/03/2003 | EP1366079A2 Nuclear hormone receptor ligand binding domain |
| 12/03/2003 | EP1366077A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 12/03/2003 | EP1366075A2 New interferon beta-like molecules |
| 12/03/2003 | EP1366074A2 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 12/03/2003 | EP1366073A2 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 12/03/2003 | EP1366072A2 Ets-transcription factor related compound specific promoter and transactivators thereof |
| 12/03/2003 | EP1366071A2 Dna-sequences, which code for an apoptosis signal transduction protein |
| 12/03/2003 | EP1366070A2 Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof |
| 12/03/2003 | EP1366068A1 Poynucleotide and polypeptide from group b streptococcus and use thereof for the preparation of a vaccine |
| 12/03/2003 | EP1366067A2 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 12/03/2003 | EP1366059A2 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 12/03/2003 | EP1366057A2 Reagents for oligonucleotide cleavage and deprotection |
| 12/03/2003 | EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 12/03/2003 | EP1365802A2 Salmonella promoter for heterologous gene expression |
| 12/03/2003 | EP1365799A1 A noval vaccine formulation consisting of dna vaccine inactivated virus |
| 12/03/2003 | EP1365790A2 Diagnostic indicator of thymic function |
| 12/03/2003 | EP1365788A2 Thrombomodulin analogs for use in recovery of signal cord injury |
| 12/03/2003 | EP1365785A2 Use of ciliary neurotrophic factor |
| 12/03/2003 | EP1365726A2 Method for evaluating therapeutic efficacy |
| 12/03/2003 | EP1365645A2 Transgenic mice containing targeted gene disruptions |
| 12/03/2003 | EP1212137B1 Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same |
| 12/03/2003 | EP1165184B1 Estrogen receptor-beta antagonism and bone diseases |
| 12/03/2003 | EP0859830B1 Growth of adult pancreatic islet cells with laminin 5 |
| 12/03/2003 | EP0832196B1 Immortalization and disimmortalization of cells |
| 12/03/2003 | EP0776367B8 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 12/03/2003 | EP0765393B1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
| 12/03/2003 | EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits |
| 12/03/2003 | EP0687295B1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 12/03/2003 | EP0631629B1 Fungus-responsive chimaeric gene |
| 12/03/2003 | EP0625573B1 Novel dna, polypeptide coded for thereby, and method of detecting both |
| 12/03/2003 | CN1460181A Nucleic acid sequences and protein involved in cellular senescence |
| 12/03/2003 | CN1460110A Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof |
| 12/03/2003 | CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides |
| 12/03/2003 | CN1460024A Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 12/03/2003 | CN1459634A Method of determining immunology |
| 12/03/2003 | CN1459507A Multi copy yeast expression carrier for proceeding correct secretory expression against exogenous gene |
| 12/03/2003 | CN1459506A Recombination expression and application of Chinese prawn antibacterial peptide gene |
| 12/03/2003 | CN1459505A Chinese Han nationality people stroma metallopankrin-9 gene reconstitution, expression, purification and its medical application |
| 12/03/2003 | CN1459504A Flowerless gene and pure nutrition growth plant type establishment and its established technical system |
| 12/03/2003 | CN1459503A Jiulian agglutinin protein and its code sequence |
| 12/03/2003 | CN1459458A Testes spermatogenous cell die related gene |
| 12/03/2003 | CN1459457A Method of producing human forcing erythrogenin using transgene animal mammary gland |
| 12/03/2003 | CN1459317A Targeting-fusion DNA vaccine for caries-prevention, and its prepn. method |
| 12/03/2003 | CN1129796C Medicine box for detecting hepatitis virus C and use thereof |